AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Results Indicate Survival Benefit For Failed Chemo Patients.(Brief Article)
2001 JUL 4 - (NewsRx.com & NewsRx.net) --
Biomira, Inc. (Nasdaq:BIOM) (TSE:BRA) announced that data from a Phase II clinical trial of Theratope(R) vaccine being tested in metastatic colorectal cancer suggest a survival benefit.
The data, from a study conducted at the University of Nebraska, centered on 45 patients and were presented at the 37th annual meeting of the American Society of Clinical Oncology (ASCO) in San Francisco, California.
The results involved patients in a metastatic colorectal cancer study, conducted by Dr. Margaret Tempero, University of California at San Francisco Comprehensive Cancer Center. Ten of the patients had metastatic rectal cancer and 35 patients had metastatic colon cancer.
Patients were randomized to receive one of three dose strengths of Theratope vaccine (1, 10, 100 units). The strongest immune responses to Theratope vaccine occurred at the highest dose tested (100 units).
Survival data were analyzed for all 45 colorectal ...
- THERATOPE Vaccine to Enter Phase III Clinical Trials.
- Press release article from: Business Wire August 20, 1997 700+ words
...treated with THERATOPE vaccine. The proposed...prospectively randomized Phase III study will provide...as to whether THERATOPE vaccine can delay disease...moving into Phase III," said Alex...and CEO. "THERATOPE vaccine is a logical...
- Biomira Analyst Conference Call Notification Theratope Vaccine Phase III...
- Press release article from: PR Newswire December 5, 2003 700+ words
...Monday, December 8, 2003 at 9:00 a.m. ET, to expand upon the previously released data on the Theratope(R) vaccine Phase III clinical trial as presented at a scientific presentation at the San Antonio Breast Cancer Symposium to be held tomorrow, December...
- Data from Theratope Vaccine trial presented.
- Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...analysis of their Theratope Vaccine phase III clinical trial...STn. The phase III trial randomized...receiving Theratope vaccine and those...impact of Theratope vaccine therapy on...June that the phase III trial of Theratope...
- Metastatic breast cancer vaccine trial to continue.(Theratope vaccine)
- Magazine article from: Women's Health Weekly November 28, 2002 700+ words
...they will continue their phase III clinical trial of Theratope vaccine through its planned conclusion...metastatic breast cancer. Theratope vaccine has fast-track designation...on the development of Theratope vaccine, reached this decision...
- Phase II colorectal trial results for theratope vaccine to be presented at ASCO.
- Newspaper article from: Gastroenterology Week April 14, 2003 700+ words
...from the company's phase II Theratope vaccine trial in metastatic colorectal...the final results from our phase III Theratope trial in 1,030...cancer. We anticipate those phase III results to be announced towards...also been notified that the phase III demography data ...
- Phase II colorectal trial results for Theratope vaccine to be presented at...
- Newspaper article from: Vaccine Weekly April 16, 2003 700+ words
...from the company's phase II Theratope vaccine trial in metastatic colorectal...the final results from our phase III Theratope trial in 1,030...cancer. We anticipate those phase III results to be announced towards...also been notified that the phase III demography data ...
- Significant survival advantage reported in phase III trial of Theratope.
- Magazine article from: Women's Health Weekly July 8, 2004 700+ words
...subset of patients receiving Theratope vaccine as part of Biomira's phase III study of the vaccine in the...Updated results from the phase III trial, including the exploratory...required to do a subsequent phase III study in order to move this...
- LARGEST EVER' TRIAL OF BREAST-CANCER DRUG BIOMIRA BEGINS PHASE III STUDY OF...
- Magazine article from: BIOWORLD Today December 1, 1998 700+ words
...breast cancer trial ever, with 900 evaluable patients in the Phase III study testing Theratope, a synthetic, carbohydrate-based...patients with metastatic breast cancer. In one Phase II study, Theratope vaccine-treated patients had a median survival of 26.6 months...
Source: HighBeam Research, Results Indicate Survival Benefit For Failed Chemo Patients.(Brief...